Satsumarx - Ownership and Business Overview

Life ScienceCompany

Satsumarx Ownership

Who owns Satsumarx?

Satsumarx is owned by Shin Nippon Biomedical Laboratories. It was acquired on April 17, 2023.

Was Satsumarx formerly PE-backed?

Yes. Satsumarx was formerly owned by 1 private investor.

Satsumarx Business Overview

Where is Satsumarx headquartered?

Satsumarx is headquartered in South San Francisco, California.

What sector is Satsumarx in?

Satsumarx is a life science company.

When was Satsumarx founded?

Satsumarx was founded in 2016.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 196 acquisitions of life science companies in 2023, including 22 acquisitions by private equity firms, and 174 by strategics.

Satsumarx

Satsuma Pharmaceuticals, Inc.

400 Oyster Point Boulevard Suite 221,
South San Francisco, California 94080
United States,
(650) 410-3200
www.satsumarx.com

Satsumarx is a clinical-stage biopharmaceutical company focused on developing STS101 as an important and differentiated therapeutic option for the acute treatment of migraines. Satsumarx was incorporated in 2016 and is headquartered in South San Francisco, California.


 Subscribe to unlock this and 206,393
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.